Semler Scientific, Inc. (NASDAQ:SMLR) Shares Sold by Greenwood Capital Associates LLC

Greenwood Capital Associates LLC cut its position in Semler Scientific, Inc. (NASDAQ:SMLR) by 4.0% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 19,978 shares of the company’s stock after selling 827 shares during the quarter. Greenwood Capital Associates LLC’s holdings in Semler Scientific were worth $470,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. CWM LLC increased its stake in shares of Semler Scientific by 486.3% during the second quarter. CWM LLC now owns 897 shares of the company’s stock worth $31,000 after acquiring an additional 744 shares during the period. Newbridge Financial Services Group Inc. acquired a new stake in Semler Scientific in the second quarter valued at $34,000. Quest Partners LLC purchased a new stake in shares of Semler Scientific in the 2nd quarter worth about $59,000. Meeder Asset Management Inc. purchased a new position in Semler Scientific during the 2nd quarter valued at about $67,000. Finally, US Bancorp DE raised its position in Semler Scientific by 60.8% during the third quarter. US Bancorp DE now owns 3,064 shares of the company’s stock worth $72,000 after acquiring an additional 1,158 shares during the last quarter. Hedge funds and other institutional investors own 49.37% of the company’s stock.

Insiders Place Their Bets

In related news, CEO Douglas Murphy-Chutorian sold 10,000 shares of the stock in a transaction on Thursday, August 29th. The stock was sold at an average price of $28.35, for a total value of $283,500.00. Following the completion of the sale, the chief executive officer now directly owns 60,220 shares in the company, valued at approximately $1,707,237. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 30.20% of the stock is currently owned by insiders.

Semler Scientific Stock Performance

SMLR stock opened at $39.00 on Wednesday. The stock’s 50 day moving average price is $26.12 and its 200 day moving average price is $28.73. The firm has a market cap of $272.61 million, a P/E ratio of 19.12 and a beta of 0.92. Semler Scientific, Inc. has a 1 year low of $20.88 and a 1 year high of $53.38.

Semler Scientific (NASDAQ:SMLR) last posted its quarterly earnings data on Monday, November 4th. The company reported $0.72 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.37 by $0.35. The business had revenue of $13.51 million for the quarter. Semler Scientific had a return on equity of 21.17% and a net margin of 25.62%.

Semler Scientific Company Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.